Enrique Samper Rodriguez

Chief Executive Officer at NIMGenetics Genómica y Medicina SL

Health Technology

Commercial Services

Profile

Enrique Samper Rodriguez is the founder and current Director of Gene Predictis SA. He founded NIMGenetics Genómica y Medicina SL in 2008 and serves as its Chief Executive Officer.

Enrique Samper Rodriguez active positions

Companies	Position	Start
NIMGenetics Genómica y Medicina SL NIMGenetics Genómica y Medicina SL Pharmaceuticals: MajorHealth Technology NIMGenetics Genómica y Medicina SL operates as a biomedical company. It specializes in the design and commercialization of products and services for clinical genetic diagnosis. The firm offers Nimfish, exonim, Trisonim, Karyonim, and Onconim products. The company was founded in 2008 and is headquartered in Madrid, Spain.	Chief Executive Officer	2007-12-31
GENE PREDICTIS SA GENE PREDICTIS SA Miscellaneous Commercial ServicesCommercial Services Part of NIMGenetics Genómica y Medicina SL, Gene Predictis SA engages in the development of diagnostic tools based on genetics that allow treatments for patients. The company is based in Lausanne, Switzerland. The Swiss company was founded in 2004. Goranka Tanackovic has been the CEO of the company since 2011. Gene Predictis was acquired by NIMGenetics Genómica y Medicina SL on February 13, 2023.	Director/Board Member	-

All active positions of Enrique Samper Rodriguez

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Enrique Samper Rodriguez's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
NIMGenetics Genómica y Medicina SL NIMGenetics Genómica y Medicina SL Pharmaceuticals: MajorHealth Technology NIMGenetics Genómica y Medicina SL operates as a biomedical company. It specializes in the design and commercialization of products and services for clinical genetic diagnosis. The firm offers Nimfish, exonim, Trisonim, Karyonim, and Onconim products. The company was founded in 2008 and is headquartered in Madrid, Spain.	Health Technology
GENE PREDICTIS SA GENE PREDICTIS SA Miscellaneous Commercial ServicesCommercial Services Part of NIMGenetics Genómica y Medicina SL, Gene Predictis SA engages in the development of diagnostic tools based on genetics that allow treatments for patients. The company is based in Lausanne, Switzerland. The Swiss company was founded in 2004. Goranka Tanackovic has been the CEO of the company since 2011. Gene Predictis was acquired by NIMGenetics Genómica y Medicina SL on February 13, 2023.	Commercial Services